The Centers for Medicare & Medicaid Services (CMS) is developing a pilot program that could change the landscape of obesity ...

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...

UnitedHealthcare says it’s dropping some of its Medicare Advantage plans that collectively cover 600,000 people.

Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...

Eli Lilly & Biogen's Alzheimer's drugs may offer minimal impact despite aggressive marketing. Click here to get insights on genetics and financial implications.

US Dollar Canadian Dollar, Eli Lilly and Company, Capital Partners SA, Novo Nordisk A/S. Read 's Market Analysis on Investing ...

Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.

Nursing homes are designed to care for patients with physical infirmities. But nationwide, 1 in 5 residents has been diagnosed with a serious mental illness, such as schizophrenia or psychosis — ...

A bone-chilling 3 degrees Celsius — for 4 minutes.Next follows a "strict routine" of exercise, supplements, IV infusions and ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...

Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...